The European Commission has approved Qalsody to treat ALS patients in the EU whose disease is associated with mutations in the SOD1 gene.| ALS News Today
The selenium elevations with Qalsody may reflect a change in the antioxidant status of nerve cells, but more research is needed.| ALS News Today